A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Anemia
Interventions: DRUG: Peginesatide
Sponsor: Takeda
Collaborators: Affymax